595 EFFICACIES OF HYBRID, HIGH-DOSE DUAL AND BISMUTH QUADRUPLE THERAPIES IN THE FIRST-LINE TREATMENT OF H PYLORI INFECTION — A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Controlled Trial ◽

High Dose ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

H Pylori ◽

Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

Medicine ◽

10.1097/md.0000000000013245 ◽

2018 ◽

Vol 97 (46) ◽

pp. e13245 ◽

Cited By ~ 2

Author(s):

Hyun Lim ◽

Chang Seok Bang ◽

Woon Geon Shin ◽

Jae Ho Choi ◽

Jae Seung Soh ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Quadruple Therapy ◽

Randomized Controlled ◽

568 An Update: A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy As First Line Treatment for H. pylori Infection in Singapore

Gastroenterology ◽

10.1016/s0016-5085(14)60376-0 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-104-S-105 ◽

Cited By ~ 1

Author(s):

Mingjun Song ◽

Tiing Leong Ang ◽

Kwong Ming Fock

Keyword(s):

Triple Therapy ◽

Controlled Trial ◽

Sequential Therapy ◽

Line Treatment ◽

Concomitant Therapy ◽

First Line ◽

Randomized Controlled ◽

H Pylori ◽

Faculty Opinions recommendation of Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718144307.793534685 ◽

2017 ◽

Author(s):

Wee Joo Chng

Keyword(s):

Arsenic Trioxide ◽

Acute Promyelocytic Leukemia ◽

Controlled Trial ◽

Promyelocytic Leukemia ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

244 A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy As First Line Treatment for H. pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(13)60190-0 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-53 ◽

Cited By ~ 4

Author(s):

Tiing Leong Ang ◽

Kwong Ming Fock ◽

Daphne Ang

Keyword(s):

Triple Therapy ◽

Controlled Trial ◽

Sequential Therapy ◽

Line Treatment ◽

Concomitant Therapy ◽

First Line ◽

Randomized Controlled ◽

H Pylori ◽

Bismuth-Based Quadruple Therapy Versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3839451 ◽

2021 ◽

Author(s):

Seung In Seo ◽

Hyun Lim ◽

Chang Seok Bang ◽

Young Joo Yang ◽

Gwang Ho Baik ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Quadruple Therapy ◽

Randomized Controlled ◽

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-016-1423-0 ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 7

Author(s):

Philip C. Schouten ◽

Gwen M. H. E. Dackus ◽

Serena Marchetti ◽

Harm van Tinteren ◽

Gabe S. Sonke ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase Ii Trial ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

Randomized Phase Ii ◽

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-017-2281-0 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 4

Author(s):

Hyuk Lee ◽

◽

Beom Jin Kim ◽

Sang Gyun Kim ◽

Jin Il Kim ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Study Protocol ◽

Controlled Trial ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-016-1195-6 ◽

2016 ◽

Vol 17 (1) ◽

Author(s):

Denise A. Yardley ◽

Adam Brufsky ◽

Robert E. Coleman ◽

Pierfranco F. Conte ◽

Javier Cortes ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C Study

Journal of Clinical Oncology ◽

10.1200/jco.2007.15.5390 ◽

2008 ◽

Vol 26 (4) ◽

pp. 689-690 ◽

Cited By ~ 174

Author(s):

Charles S. Fuchs ◽

John Marshall ◽

José Barrueco

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Oral Fluoropyrimidines ◽

Randomized Controlled ◽

Efficacy of Combined Anticholinergic Treatment and Behavioral Modification as a First Line Treatment for Nonneurogenic and Nonanatomical Voiding Dysfunction in Children: A Randomized Controlled Trial

The Journal of Urology ◽

10.1016/j.juro.2007.02.001 ◽

2007 ◽

Vol 177 (6) ◽

pp. 2325-2329 ◽

Cited By ~ 23

Author(s):

S. Ayan ◽

K. Topsakal ◽

G. Gokce ◽

E.Y. Gultekin

Keyword(s):

Voiding Dysfunction ◽

Controlled Trial ◽

Behavioral Modification ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽